BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 10196223)

  • 21. IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways.
    Schraufstatter IU; Chung J; Burger M
    Am J Physiol Lung Cell Mol Physiol; 2001 Jun; 280(6):L1094-103. PubMed ID: 11350788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PAK1 kinase is required for CXCL1-induced chemotaxis.
    Wang D; Sai J; Carter G; Sachpatzidis A; Lolis E; Richmond A
    Biochemistry; 2002 Jun; 41(22):7100-7. PubMed ID: 12033944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rab11-family interacting protein 2 and myosin Vb are required for CXCR2 recycling and receptor-mediated chemotaxis.
    Fan GH; Lapierre LA; Goldenring JR; Sai J; Richmond A
    Mol Biol Cell; 2004 May; 15(5):2456-69. PubMed ID: 15004234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. beta-arrestins regulate interleukin-8-induced CXCR1 internalization.
    Barlic J; Khandaker MH; Mahon E; Andrews J; DeVries ME; Mitchell GB; Rahimpour R; Tan CM; Ferguson SS; Kelvin DJ
    J Biol Chem; 1999 Jun; 274(23):16287-94. PubMed ID: 10347185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Src-mediated tyrosine phosphorylation of dynamin is required for beta2-adrenergic receptor internalization and mitogen-activated protein kinase signaling.
    Ahn S; Maudsley S; Luttrell LM; Lefkowitz RJ; Daaka Y
    J Biol Chem; 1999 Jan; 274(3):1185-8. PubMed ID: 9880482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of a dominant interfering dynamin mutant in 3T3L1 adipocytes inhibits GLUT4 endocytosis without affecting insulin signaling.
    Kao AW; Ceresa BP; Santeler SR; Pessin JE
    J Biol Chem; 1998 Sep; 273(39):25450-7. PubMed ID: 9738014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXC chemokines suppress proliferation of myeloid progenitor cells by activation of the CXC chemokine receptor 2.
    Sanchez X; Suetomi K; Cousins-Hodges B; Horton JK; Navarro J
    J Immunol; 1998 Jan; 160(2):906-10. PubMed ID: 9551928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2.
    Ludwig A; Petersen F; Zahn S; Götze O; Schröder JM; Flad HD; Brandt E
    Blood; 1997 Dec; 90(11):4588-97. PubMed ID: 9373270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CXCR1 and CXCR2 are rapidly down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism.
    Khandaker MH; Xu L; Rahimpour R; Mitchell G; DeVries ME; Pickering JG; Singhal SK; Feldman RD; Kelvin DJ
    J Immunol; 1998 Aug; 161(4):1930-8. PubMed ID: 9712063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation.
    Richardson RM; Pridgen BC; Haribabu B; Ali H; Snyderman R
    J Biol Chem; 1998 Sep; 273(37):23830-6. PubMed ID: 9726994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aquaporin-2 localization in clathrin-coated pits: inhibition of endocytosis by dominant-negative dynamin.
    Sun TX; Van Hoek A; Huang Y; Bouley R; McLaughlin M; Brown D
    Am J Physiol Renal Physiol; 2002 Jun; 282(6):F998-1011. PubMed ID: 11997316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation of functional roles of dynamin in receptor-mediated endocytosis and mitogenic signal transduction.
    Whistler JL; von Zastrow M
    J Biol Chem; 1999 Aug; 274(35):24575-8. PubMed ID: 10455121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combinatorial model of chemokine involvement in glomerular monocyte recruitment: role of CXC chemokine receptor 2 in infiltration during nephrotoxic nephritis.
    Zernecke A; Weber KS; Erwig LP; Kluth DC; Schröppel B; Rees AJ; Weber C
    J Immunol; 2001 May; 166(9):5755-62. PubMed ID: 11313419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2.
    Katancik JA; Sharma A; de Nardin E
    Cytokine; 2000 Oct; 12(10):1480-8. PubMed ID: 11023662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis.
    Cummings CJ; Martin TR; Frevert CW; Quan JM; Wong VA; Mongovin SM; Hagen TR; Steinberg KP; Goodman RB
    J Immunol; 1999 Feb; 162(4):2341-6. PubMed ID: 9973513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway.
    Chandrasekar B; Melby PC; Sarau HM; Raveendran M; Perla RP; Marelli-Berg FM; Dulin NO; Singh IS
    J Biol Chem; 2003 Feb; 278(7):4675-86. PubMed ID: 12468547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clathrin- and dynamin-dependent endocytosis limits canonical NF-κB signaling triggered by lymphotoxin β receptor.
    Maksymowicz M; Miączyńska M; Banach-Orłowska M
    Cell Commun Signal; 2020 Nov; 18(1):176. PubMed ID: 33148272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression.
    Khandaker MH; Mitchell G; Xu L; Andrews JD; Singh R; Leung H; Madrenas J; Ferguson SS; Feldman RD; Kelvin DJ
    Blood; 1999 Apr; 93(7):2173-85. PubMed ID: 10090924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The C-terminal domain LLKIL motif of CXCR2 is required for ligand-mediated polarization of early signals during chemotaxis.
    Sai J; Fan GH; Wang D; Richmond A
    J Cell Sci; 2004 Nov; 117(Pt 23):5489-96. PubMed ID: 15479720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells.
    Lippert U; Artuc M; Grützkau A; Möller A; Kenderessy-Szabo A; Schadendorf D; Norgauer J; Hartmann K; Schweitzer-Stenner R; Zuberbier T; Henz BM; Krüger-Krasagakes S
    J Immunol; 1998 Sep; 161(5):2600-8. PubMed ID: 9725262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.